SOPHiA GENETICS SA (SOPH)
Every FINRA and SEC series the site collects for SOPHiA GENETICS SA: short interest with days to cover, daily short sale volume, fails to deliver and Form 4 insider trades. Listed on Nasdaq, classified by the SEC as services-computer processing & data preparation.
931K
Short interest
settlement 2026-08-14
1.7
Days to cover
+21.1% vs prior
57.7%
Short share of volume
2026-09-11
22,012
Fails to deliver
settlement 2026-08-14
-$1.8M
Insider flow, 90 days
0 buys, 27 sells
As of 2026-09-11.
Short interest
FINRA, twice a month; the last 12 months shown, all 48 settlements in the JSONAs of 14 August 2026, short interest in SOPH is 930,712 shares, up 269,360 shares over the last month. Over the last 48 readings it ranged from 14,456 shares (15 October 2024) to 930,712 shares (14 August 2026). The latest reading sits at the top of that range. At the reported average volume of 558K shares a day that is 1.7 days to cover.
Embed this chartfree, with the attribution line it carries
<iframe src="https://xoomar.com/embed/stocks/soph" width="100%" height="440" style="border:0;max-width:100%" loading="lazy" title="XOOMAR chart"></iframe>
| Settlement | Shares short | Change | Avg daily volume | Days to cover |
|---|---|---|---|---|
| 2026-08-14 | 930,712 | +21.1% | 557,829 | 1.67 |
| 2026-07-31 | 768,289 | +16.2% | 290,198 | 2.65 |
| 2026-07-15 | 661,352 | +4.0% | 313,792 | 2.11 |
| 2026-06-30 | 636,132 | +141.3% | 459,329 | 1.38 |
| 2026-06-15 | 263,601 | -5.5% | 140,941 | 1.87 |
| 2026-05-29 | 279,103 | +18.9% | 64,910 | 4.30 |
| 2026-05-15 | 234,741 | +18.3% | 119,046 | 1.97 |
| 2026-04-30 | 198,408 | +12.8% | 97,328 | 2.04 |
| 2026-04-15 | 175,963 | -31.0% | 92,994 | 1.89 |
| 2026-03-31 | 254,959 | +20.3% | 96,355 | 2.65 |
| 2026-03-13 | 211,974 | +16.0% | 125,577 | 1.69 |
| 2026-02-27 | 182,807 | -19.1% | 90,033 | 2.03 |
| 2026-02-13 | 226,049 | +194.3% | 258,111 | 1.00 |
| 2026-01-30 | 76,808 | +44.8% | 462,687 | 1.00 |
| 2026-01-15 | 53,042 | +68.3% | 137,142 | 1.00 |
| 2025-12-31 | 31,511 | -2.9% | 41,289 | 1.00 |
| 2025-12-15 | 32,434 | -26.5% | 99,157 | 1.00 |
| 2025-11-28 | 44,138 | -8.1% | 109,152 | 1.00 |
| 2025-11-14 | 48,035 | -65.1% | 93,276 | 1.00 |
| 2025-10-31 | 137,679 | +532.3% | 159,541 | 1.00 |
| 2025-10-15 | 21,773 | -34.4% | 103,642 | 1.00 |
| 2025-09-30 | 33,207 | +40.3% | 108,438 | 1.00 |
| 2025-09-15 | 23,673 | -45.5% | 34,541 | 1.00 |
| 2025-08-29 | 43,419 | +6.2% | 43,270 | 1.00 |
Daily short volume
FINRA Reg SHO, last 60 sessions. JSONAs of 11 September 2026, the short share of SOPH volume is 57.7%, up 36.4 points over the last five sessions. Over the last 52 readings it ranged from 11.5% (1 September 2026) to 69.9% (31 July 2026). The latest reading is 21.5 points above the 30-session average of 36.2%, on 123K shares reported.
| Date | Short volume | Total volume | Short share | Exempt |
|---|---|---|---|---|
| 2026-09-11 | 71K | 123K | 57.7% | 287 |
| 2026-09-10 | 83K | 201K | 41.0% | 76 |
| 2026-09-09 | 161K | 447K | 36.0% | 92 |
| 2026-09-08 | 76K | 312K | 24.4% | 9 |
| 2026-09-04 | 35K | 57K | 62.0% | 0 |
| 2026-09-03 | 98K | 460K | 21.2% | 648 |
| 2026-09-02 | 129K | 479K | 26.8% | 8,665 |
| 2026-09-01 | 55K | 480K | 11.5% | 58 |
| 2026-08-31 | 109K | 430K | 25.3% | 135 |
| 2026-08-28 | 82K | 196K | 41.9% | 267 |
| 2026-08-27 | 113K | 236K | 48.0% | 2,352 |
| 2026-08-26 | 26K | 78K | 33.5% | 3,100 |
| 2026-08-25 | 98K | 484K | 20.3% | 1,200 |
| 2026-08-24 | 98K | 221K | 44.4% | 7,854 |
| 2026-08-21 | 68K | 185K | 36.7% | 14,897 |
| 2026-08-20 | 126K | 279K | 45.1% | 17,512 |
| 2026-08-19 | 296K | 776K | 38.1% | 33,158 |
| 2026-08-18 | 55K | 219K | 25.2% | 12,867 |
| 2026-08-17 | 28K | 93K | 30.1% | 9,336 |
| 2026-08-14 | 24K | 81K | 29.4% | 3,414 |
| 2026-08-13 | 28K | 85K | 32.5% | 6,378 |
| 2026-08-12 | 41K | 88K | 46.0% | 16,398 |
| 2026-08-11 | 31K | 94K | 32.5% | 6,133 |
| 2026-08-10 | 68K | 149K | 45.7% | 24,510 |
| 2026-08-07 | 118K | 326K | 36.2% | 17,237 |
| 2026-08-06 | 52K | 178K | 29.0% | 439 |
| 2026-08-05 | 79K | 307K | 25.8% | 996 |
| 2026-08-04 | 172K | 728K | 23.6% | 7,878 |
| 2026-08-03 | 63K | 136K | 46.2% | 0 |
| 2026-07-31 | 17K | 25K | 69.9% | 100 |
Fails to deliver
SEC, by settlement date. JSONAs of 14 August 2026, the fails-to-deliver balance in SOPH is 22,012 shares, up 2,902 shares over the last settlement date. Over the last 52 readings it ranged from 5 shares (8 June 2026) to 110,163 shares (5 August 2026).
| Settlement | Shares failed | Price | Value |
|---|---|---|---|
| 2026-08-14 | 22,012 | $7.62 | $168K |
| 2026-08-13 | 19,110 | $7.57 | $145K |
| 2026-08-12 | 24,129 | $7.61 | $184K |
| 2026-08-11 | 44,814 | $7.67 | $344K |
| 2026-08-10 | 12,889 | $7.71 | $99K |
| 2026-08-05 | 110,163 | $6.84 | $754K |
| 2026-08-04 | 25,117 | $5.69 | $143K |
| 2026-08-03 | 4,496 | $5.67 | $25K |
| 2026-07-31 | 3,284 | $5.76 | $19K |
| 2026-07-30 | 1,949 | $5.55 | $11K |
| 2026-07-29 | 1,962 | $5.57 | $11K |
| 2026-07-28 | 7,671 | $5.65 | $43K |
| 2026-07-27 | 2,635 | $5.72 | $15K |
| 2026-07-24 | 12,020 | $6.05 | $73K |
| 2026-07-23 | 38,091 | $6.40 | $244K |
| 2026-07-21 | 23,557 | $6.33 | $149K |
| 2026-07-20 | 10,472 | $5.87 | $61K |
| 2026-07-17 | 156 | $5.83 | $909 |
| 2026-07-16 | 1,434 | $5.77 | $8K |
| 2026-07-14 | 28,203 | $5.72 | $161K |
| 2026-07-13 | 13,679 | $5.65 | $77K |
| 2026-07-10 | 13,008 | $5.82 | $76K |
| 2026-07-09 | 822 | $5.51 | $5K |
| 2026-07-07 | 68 | $5.34 | $363 |
| 2026-07-02 | 10,035 | $5.59 | $56K |
| 2026-07-01 | 22,271 | $5.77 | $129K |
| 2026-06-30 | 7,104 | $5.98 | $42K |
| 2026-06-29 | 27,525 | $5.75 | $158K |
| 2026-06-25 | 5,615 | $5.52 | $31K |
| 2026-06-23 | 93 | $5.34 | $497 |
Insider trades
SEC Form 4, newest first, 50 of 100 shown. JSONInsiders at SOPH reported 27 open-market sells worth $1.8M in the last 90 days and no open-market buys. Sells alone are a weak signal; insiders sell for tax, diversification and estate reasons all the time. Latest filing: Xu Zhenyu (Chief Scientific Officer) on 2026-08-27.
| Date | Insider | Title | Type | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|---|
| 2026-08-27 | Xu Zhenyu | Chief Scientific Officer | Sell | 10K | $8.91 | $89K | 557K |
| 2026-08-25 | Menu Philippe | Chief Medical Officer | Sell | 5K | $8.68 | $43K | 213K |
| 2026-08-25 | HIBBS KATHY L | n/a | Sell | 6K | $8.68 | $54K | 103K |
| 2026-08-24 | Verma Abhimanyu | Chief Technology Officer | Sell | 5K | $8.80 | $44K | 172K |
| 2026-08-21 | Xu Zhenyu | Chief Scientific Officer | Sell | 5K | $8.40 | $45K | 567K |
| 2026-08-20 | Xu Zhenyu | Chief Scientific Officer | Sell | 5K | $8.41 | $39K | 572K |
| 2026-08-19 | Verma Abhimanyu | Chief Technology Officer | Sell | 5K | $8.20 | $41K | 177K |
| 2026-08-19 | Valente Manuela | Chief People Officer | Sell | 10K | $7.94 | $79K | 210K |
| 2026-08-19 | Valente Manuela | Chief People Officer | Option exercise | 10K | $3.20 | $32K | 220K |
| 2026-08-19 | Xu Zhenyu | Chief Scientific Officer | Sell | 10K | $7.94 | $79K | 577K |
| 2026-08-13 | Xu Zhenyu | Chief Scientific Officer | Sell | 4K | $7.52 | $30K | 587K |
| 2026-08-12 | Menu Philippe | Chief Medical Officer | Sell | 5K | $7.52 | $38K | 218K |
| 2026-08-10 | Camblong Jurgi | Executive Chairman | Sell | 9K | $7.61 | $65K | 3.4M |
| 2026-08-07 | Verma Abhimanyu | Chief Technology Officer | Sell | 5K | $7.60 | $38K | 182K |
| 2026-08-07 | Camblong Jurgi | Executive Chairman | Sell | 20K | $7.23 | $145K | 3.5M |
| 2026-08-07 | Xu Zhenyu | Chief Scientific Officer | Sell | 10K | $7.48 | $75K | 591K |
| 2026-08-07 | Xu Zhenyu | Chief Scientific Officer | Sell | 7K | $7.02 | $49K | 601K |
| 2026-08-07 | Xu Zhenyu | Chief Scientific Officer | Option exercise | 7K | $3.28 | $23K | 608K |
| 2026-08-05 | Xu Zhenyu | Chief Scientific Officer | Sell | 3K | $7.00 | $21K | 601K |
| 2026-08-05 | Xu Zhenyu | Chief Scientific Officer | Option exercise | 3K | $3.28 | $10K | 604K |
| 2026-08-04 | Verma Abhimanyu | Chief Technology Officer | Sell | 5K | $6.95 | $35K | 187K |
| 2026-08-04 | Xu Zhenyu | Chief Scientific Officer | Sell | 10K | $6.92 | $69K | 601K |
| 2026-08-04 | Camblong Jurgi | Executive Chairman | Sell | 20K | $6.92 | $138K | 3.5M |
| 2026-07-21 | Camblong Jurgi | Executive Chairman | Sell | 20K | $6.63 | $133K | 3.5M |
| 2026-07-20 | Camblong Jurgi | Executive Chairman | Sell | 5K | $6.17 | $28K | 3.5M |
| 2026-07-20 | Camblong Jurgi | Executive Chairman | Option exercise | 5K | $3.16 | $14K | 3.5M |
| 2026-07-20 | Camblong Jurgi | Executive Chairman | Sell | 20K | $6.32 | $125K | 3.5M |
| 2026-07-10 | Camblong Jurgi | Executive Chairman | Sell | 9K | $5.62 | $48K | 3.5M |
| 2026-07-07 | Camblong Jurgi | Executive Chairman | Sell | 18K | $5.28 | $93K | 3.5M |
| 2026-07-06 | Camblong Jurgi | Executive Chairman | Sell | 22K | $5.25 | $118K | 3.6M |
| 2026-07-06 | CARDOZA GEORGE | Chief Financial Officer | Sell | 2K | $5.29 | $8K | 309K |
| 2026-06-10 | Camblong Jurgi | Chief Executive Officer | Sell | 9K | $5.24 | $45K | 3.6M |
| 2026-06-05 | CARDOZA GEORGE | Chief Financial Officer | Buy | 20K | $4.95 | $99K | 311K |
| 2026-05-26 | Menu Philippe | Chief Medical Officer | Sell | 5K | $4.95 | $25K | 251K |
| 2026-05-19 | Xu Zhenyu | Chief Scientific Officer | Sell | 608 | $4.60 | $3K | 626K |
| 2026-05-19 | Van Well Daan | Chief Legal Officer | Sell | 684 | $4.60 | $3K | 345K |
| 2026-05-19 | Valente Manuela | Chief People Officer | Sell | 380 | $4.60 | $2K | 215K |
| 2026-05-19 | Puylaert Kevin | Chief Sales Officer | Sell | 33 | $4.54 | $150 | 148K |
| 2026-05-19 | Muken Ross | President | Sell | 761 | $4.60 | $4K | 681K |
| 2026-05-19 | Menu Philippe | Chief Medical Officer | Sell | 608 | $4.61 | $3K | 256K |
| 2026-05-19 | Camblong Jurgi | Chief Executive Officer | Sell | 4K | $4.60 | $21K | 3.6M |
| 2026-05-13 | Xu Zhenyu | Chief Scientific Officer | Sell | 4K | $4.54 | $18K | 627K |
| 2026-05-12 | Menu Philippe | Chief Medical Officer | Sell | 5K | $4.67 | $23K | 256K |
| 2026-05-12 | HIBBS KATHY L | n/a | Sell | 8K | $4.67 | $35K | 90K |
| 2026-05-11 | Camblong Jurgi | Chief Executive Officer | Sell | 9K | $5.09 | $43K | 3.6M |
| 2026-04-27 | Menu Philippe | Chief Medical Officer | Sell | 5K | $4.82 | $24K | 261K |
| 2026-04-20 | Valente Manuela | Chief People Officer | Sell | 380 | $5.20 | $2K | 215K |
| 2026-04-20 | Xu Zhenyu | Chief Scientific Officer | Sell | 608 | $5.21 | $3K | 631K |
| 2026-04-20 | Van Well Daan | Chief Legal Officer | Sell | 684 | $5.20 | $4K | 346K |
| 2026-04-20 | Puylaert Kevin | Chief Sales Officer | Sell | 33 | $5.08 | $168 | 148K |
Form 4 filings are due within two business days of the trade. Insiders sell for many reasons that say nothing about the company; open-market buys are the rarer, stronger signal.
Planned sales (Form 144)
Newest first. JSON12 Form 144 notices on file for SOPH worth $1.3M at the prices reported; 12 in the last 90 days worth $1.3M. Latest: DAAN GUIDO MARIA VAN WELL filed on 2026-09-11 to sell 6,168 shares ($47K) from 2026-09-11.
| Filed | Seller | Shares | Market value | Of outstanding | Sale from | Broker |
|---|---|---|---|---|---|---|
| 2026-09-11 | DAAN GUIDO MARIA VAN WELLOfficer | 6K | $47K | 0.007% | 2026-09-11 | Morgan Stanley Smith Barney LLC Executive Financial Services |
| 2026-08-27 | ZHENYU XUOfficer | 14K | $119K | 0.016% | 2026-08-27 | Morgan Stanley Smith Barney LLC Executive Financial Services |
| 2026-08-25 | KATHY L HIBBSDirector | 19K | $158K | 0.022% | 2026-08-25 | Morgan Stanley Smith Barney LLC Executive Financial Services |
| 2026-08-20 | ZHENYU XUOfficer | 6K | $50K | 0.007% | 2026-08-20 | Morgan Stanley Smith Barney LLC Executive Financial Services |
| 2026-08-19 | MANUELA VALENTEOfficer | 10K | $76K | 0.012% | 2026-08-19 | Morgan Stanley Smith Barney LLC Executive Financial Services |
| 2026-08-19 | ZHENYU XUOfficer | 8K | $61K | 0.009% | 2026-08-19 | Morgan Stanley Smith Barney LLC Executive Financial Services |
| 2026-08-07 | ZHENYU XUOfficer | 22K | $147K | 0.026% | 2026-08-07 | Morgan Stanley Smith Barney LLC Executive Financial Services |
| 2026-08-07 | JURGI CAMBLONGDirector, Officer | 20K | $134K | 0.023% | 2026-08-07 | Morgan Stanley Smith Barney LLC Executive Financial Services |
| 2026-08-04 | ZHENYU XUOfficer | 10K | $57K | 0.012% | 2026-08-04 | Morgan Stanley Smith Barney LLC Executive Financial Services |
| 2026-08-04 | JURGI CAMBLONGDirector, Officer | 20K | $114K | 0.023% | 2026-08-04 | Morgan Stanley Smith Barney LLC Executive Financial Services |
| 2026-07-21 | JURGI CAMBLONGDirector, Officer | 37K | $234K | 0.052% | 2026-07-21 | Morgan Stanley Smith Barney LLC Executive Financial Services |
| 2026-07-20 | JURGI CAMBLONGDirector, Officer | 24K | $143K | 0.034% | 2026-07-20 | Morgan Stanley Smith Barney LLC Executive Financial Services |
13F holders
Tracked managers holding SOPH at their latest 13F. JSON4 of the 30 tracked managers held SOPH at their latest 13F, $2.9M in total at quarter-end prices. Citadel Advisors is the largest at $1.1M (0.0% of its portfolio) as of 2026-06-30. Over the prior quarter 3 added shares and 1 cut.
| Fund | Quarter | Shares | Value | Of portfolio | Change in shares |
|---|---|---|---|---|---|
| Citadel Advisors | 2026-06-30 | 187K | $1.1M | 0.00% | +158K |
| Millennium Management | 2026-06-30 | 138K | $799K | 0.00% | -87K |
| Renaissance Technologies | 2026-06-30 | 113K | $654K | 0.00% | +54K |
| Two Sigma Investments | 2026-06-30 | 58K | $337K | 0.00% | +48K |
Only the 30 tracked managers on the funds hub; a 13F reports long positions in US listed stock at quarter end, 45 days late, and says nothing about shorts or positions sold since.
What this page is
SOPHiA GENETICS SA in the regulatory record
Regulators publish company data in separate files that never sit next to each other: FINRA's twice-monthly short interest, its daily short sale volume, the SEC's fails-to-deliver counts, and each insider's Form 4. A company page pulls every series the site collects for one ticker onto one URL, keyed by the SEC's own ticker list, so the short position, the daily flow, the settlement fails and what insiders are doing can be read together.
Each section has its own history table, a summary sentence built from the rows (last value, change, range with dates) and its own JSON and CSV links. Nothing on the page is written by a model; the sentences change only when the data does. A page exists only for companies with data in at least two series, and every section says when its source last updated.
This page follows SOPHiA GENETICS SA (SOPH), SEC CIK 1840706, listed on Nasdaq, classified by the SEC as services-computer processing & data preparation. The cross-market tables live on the short interest and insider transactions hubs.
Source and method
- Short interest
- FINRA consolidated short interestTwice a month, about eight business days after settlement. Latest 2026-08-14.JSON and CSV
- Daily short volume
- FINRA Reg SHO daily filesEvery trading day, loaded the following morning. Latest 2026-09-11.JSON and CSV
- Fails to deliver
- SEC fails-to-deliver dataTwice a month, a few weeks after the half month ends. Latest 2026-08-14.JSON and CSV
- Planned sales
- SEC EDGAR Form 144EDGAR read every 30 minutes; a notice is filed on or before the sell order. Latest 2026-09-11.JSON and CSV
- 13F holders
- SEC EDGAR Form 13F-HRQuarterly, filed within 45 days of quarter end; 30 tracked managers. Latest 2026-06-30.JSON and CSV
- Insider trades
- SEC EDGAR Form 4EDGAR read every 30 minutes; filings are due two business days after the trade. Latest 2026-08-27.JSON and CSV
- Company record
- EDGAR filing index for CIK 1840706Ticker, name and exchange from the SEC's company list, refreshed weekly.
- Rate limits
- 30 requests a minute without a key, 120 a minute with a key from a free account.
Data checks. Every dataset is checked against its source once a day. This dataset passed the last run, 13 Sep 05:40 UTC.
How to read it
- Read the position against the flow: rising short interest with a high daily short share is new shorting; rising short interest with a normal short share is old shorts holding on.
- Insider buys next to a crowded short are the combination that has historically preceded squeezes; insider sells next to a crowded short are common and mean little.
- Fails to deliver matter relative to the float, not in absolute shares; a million failed shares in a mega cap is noise.
Analysis of what the data shows, not advice. XOOMAR does not recommend buying, selling or holding anything.
Other companies the SEC classifies as services-computer processing & data preparation
- RDDTReddit, Inc.
- PEGAPEGASYSTEMS INC
- WDAYWorkday, Inc.
- ADPAUTOMATIC DATA PROCESSING INC
- RNGRingCentral, Inc.
- LIFLife360, Inc.
- HNGEHinge Health, Inc.
- INODINNODATA INC
- RAMPLiveRamp Holdings, Inc.
- QBTSD-Wave Quantum Inc.
- CARGCarGurus, Inc.
- IBEXIBEX Ltd
- VRSKVerisk Analytics, Inc.
- OOMAOOMA INC
- TRAKReposiTrak, Inc.
- INFQInfleqtion, Inc.
- FIVNFive9, Inc.
- CLVTCLARIVATE PLC
- EGHT8X8 INC /DE/
- DXCDXC Technology Co
- TOSTToast, Inc.
- MOVECorvex, Inc.
- LIFXLife360, Inc.
- CRWVCoreWeave, Inc.
Datasets
Frequently Asked Questions
How much of SOPH is sold short?
What is SOPH's daily short volume?
Does SOPH have fails to deliver?
Are SOPH insiders buying or selling?
Have SOPH insiders filed to sell?
Which funds hold SOPH?
Data on this page is provided for informational purposes only and is not financial advice. See our editorial policy.